A. Padilla

Evaluation of two International Reference Standards for antibodies to Trypanosoma cruzi in a WHO collaborative study

S. Rijpkema, J. Hockley, P. Rigsby, 2011 .

WHO Expert Committee on Biological Standardization.

P. Minor, T. Burnouf, A. Padilla, 2004, World Health Organization technical report series.

The biological properties, assay, and standardization of interferon-alpha: a need for a WHO collaborative study.

R. Thorpe, A. Mire-Sluis, K. Zoon, 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Current strategies to prevent transmission of prions by human plasma derivatives.

T. Burnouf, A. Padilla, 2006, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents.

R. G. Das, A. Mire-Sluis, A. Padilla, 1998, Journal of immunological methods.

WHO Expert Committee on Biological Standardization: highlights of the 50th meeting, October 1999.

D. Wood, E. Griffiths, A. Padilla, 1999, Biologicals : journal of the International Association of Biological Standardization.

Assessment of the viral safety of antivenoms fractionated from equine plasma

J. Gutiérrez, M. A. Stephano, E. Griffiths, 2004, Biologicals.

WHO activities towards the three Rs in the development and control of biological products.

J Milstien, V. Grachev, J. Milstien, 1996, Developments in biological standardization.

International standards for minimum potency of anti‐A and anti‐B blood grouping reagents: evaluation of candidate preparations in an international collaborative study

A. Heath, B. Fox, S. Thorpe, 2006, Vox sanguinis.

Biological assays: their role in the development and quality control of recombinant biological medicinal products.

R. G. Das, R. Thorpe, A. Mire-Sluis, 1996, Biologicals : journal of the International Association of Biological Standardization.